Fighting Cancer via PROTACs, RIPTACs, and the Downmodulation of a Transcription Factor

Professor Craig Crews during the interview session. Credit: The Habibat Project

PROTACs (PROteolysis TArgeting Chimeras) were first introduced in 2001 to help remove specific unwanted protein growths, with the potential to target and destroy disease-causing protein tumors. This technology now presents a promising alternative to chemotherapy and precision…